Akouos Inc

NASDAQ:AKUS   3:59:58 PM EDT
5.09
+0.44 (+9.46%)
Products

Akouos Receives FDA Clearance Of Its IND Application For AK-OTOF, A Gene Therapy Intended For The Treatment Of OTOF-Mediated Hearing Loss

Published: 09/13/2022 11:10 GMT
Akouos Inc (AKUS) - Akouos Receives FDA Clearance of Its Ind Application for Ak-otof, a Gene Therapy Intended for the Treatment of Otof-mediated Hearing Loss.
Akouos Receives FDA Clearance of Its Ind Application for Ak-otof, a Gene Therapy Intended for the Treatment of Otof-mediated Hearing Loss.
Akouos Inc - Plans to Initiate a Pediatric Phase 1/2 Clinical Trial, Including Children As Young As Two Years of Age in Dose-escalation Phase (part A).